PR Newswire Asia's news > Biotechnology

 < Previous page   |   Detail   |   Print    Next page > 
     
Piramal Pharma Solutions Announces Partnership with Botanix to Support Drug Substance Development
2026-05-18T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
MS Pharma Announces Strategic Growth Investment from Olayan Financing Company
2026-05-18T    Banking/Financial Service   Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Earendil Labs Announces First Cohort Dosed in Phase I Study of Novel Biparatopic Antibody Targeting Thymic Stromal Lymphopoietin (TSLP)
2026-05-18T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Lundbeck receives orphan drug designation in Japan for asedebart for the treatment of patients with congenital adrenal hyperplasia and Cushing's disease
2026-05-18T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Harbour BioMed Announces Promising Preclinical Data for LET003, Its First AI-Enabled Drug Candidate
2026-05-18T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
WuXi AppTec Recognized as a Top-Performing Company on 2026 Dow Jones Best-in-Class World Index
2026-05-18T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
LOTTE Biologics Expands Antibody Manufacturing Agreement with Ottimo Pharma
2026-05-18T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Atisama Therapeutics Advances RB042 into Multiple Ascending Dose cohorts of Phase 1 Trial and Appoints Bernard Coulie as Chair of the Board
2026-05-15T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Racura Oncology Announces Positive Safety Review Committee Recommendation in ongoing CPACS Clinical Trial
2026-05-15T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Phase II Data from a Randomized Double-Blind Trial of Ligufalimab (Anti-CD47) Combination Therapy in Frontline AML Published at EHA 2026
2026-05-15T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

 

88iv | Home |  Login
Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer
Copyright (C) 2026
Suntek Computer Systems Limited.
All rights reserved